Top 10: CEOs in MedTech

Medical Technology (MedTech) encompasses the diverse range of digital tools, devices and software designed to improve patient outcomes.

As AI diagnostics and robotic surgery redefine the clinical landscape, the sector faces regulatory and ethical complexities.

Navigating these challenges requires decisive leadership capable of balancing rapid innovation with rigorous safety standards.

Healthcare Digital explores the top 10 CEOs in the MedTech industry, ranked by their company's revenue.

10. Helen Giza

Company: Fresenius Medical Care
Revenue: US$21.6bn
CEO since: 2022

Helen Giza is the CEO of Fresenius Medical Care, with more than 30 years of experience across the healthcare, MedTech and pharmaceutical sectors.

She joined Fresenius in 2019 as its Chief Financial Officer, after spending more than 11 years at Takeda and five years at Abbott.

Fresenius's MedTech portfolio includes solutions for nutrition and infusion therapies, blood and plasma donations and processing and cell therapies.

9. Tom Polen

Company: BD
Revenue: US$21.8bn
CEO since: 2020

Tom Polen is the CEO of BD, a leading MedTech company focusing on diagnostics, drug delivery systems and laboratory automation.

He has been with the company for 18 years, joining in 2008 as President, Preanalytical Systems.

He held the roles of Group President of BD Medical Surgical Systems and BD Pharmaceutical Systems and Chief Operating Officer before taking on his current role.

Prior to this, he spent four years working at Baxter International.

8. Rainer M. Blair

Company: Danaher
Revenue: US$24.6bn
CEO since: 2020

Rainer M. Blair is President and CEO of Danaher, where he leads the company's US$24bn global portfolio.

He works alongside 63,000 global associates to enhance Danaher's position as a leading science and technology innovator.

Rainer says: "Our culture of continuous improvement enables us to solve problems and deliver innovation for our customers, invest strategically and accelerate our growth, ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow."

7. Kevin Lobo

Company: Stryker
Revenue: US$25.12bn
CEO since: 2012

Kevin Lobo is the Chair and CEO of Stryker, previously serving as Group President of Orthopaedics.

Under his leadership, the company has completed more than 60 acquisitions and advanced innovation and global market presence.

He has been named on Forbes's list of America's Most Innovative Leaders.

Kevin said on LinkedIn: "Our unique operating model and differentiated culture allow us to deliver technologies that help our customers change lives.

"We have a strong new product pipeline that will continue this positive trajectory and make a meaningful difference for customers and patients."

6. Bernd Montag

Company: Siemens Healthineers
Revenue: US$26.87bn
CEO since: 2015

Bernd Montag is CEO of Siemens Healthineers. He has worked at Siemens since 1995.

He has held positions in corporate quality management and sales in the hearing aid business before moving to the imaging systems unit in 1999.

In 2008, he took on the role of President of the imaging and therapy division, where he gained experience and knowledge that he brings to his current role as CEO.

Siemens Healthineers focuses on all aspects of MedTech, including patient twinning, precision therapy, AI, diagnostics and image-guided therapy.

5. Jim Boyle

Company: Medline
Revenue: US$28.4bn
CEO since: 2023

Jim Boyle is CEO of Medline Industries, where he has worked for nearly 30 years.

He joined the company in 1996 as a Senior Account Manager.

Medline has a wide range of products, including patient care products, diagnostic instruments, operating theatre products, suction systems and anaesthesia products.

Jim writes on LinkedIn: "As Medline CEO, I am dedicated to making lasting commitments to our employees and customers so that we can continue providing swift, tailored solutions that help improve the efficiency of healthcare."

4. Robert B. Ford

Company: Abbott
Revenue: US$30.31bn
CEO since: 2020

Robert B. Ford is the Chairman and CEO of Abbott, previously serving as Chief Operating Officer and EVP, Medical Devices.

He started his career in 1995 as a Product Manager at BD, before joining Abbott in 1996.

Abbott provides diabetes products, including the FreeStyle Libre systems to measure glucose and help people track their habits.

Robert says: "The key to Abbott's success for nearly 140 years has been strong leadership based on strong values and a commitment to running our business according to the highest ethical standards."

3. Francesco Milleri

Company: EssilorLuxottica
Revenue: US$31.3bn
CEO since: 2020

Francesco Milleri is the Chairman and CEO of EssilorLuxottica, which is a global leader in the eyewear and eyecare industry.

He has been part of the company since 2016, joining as Deputy Chairman of Luxottica before its merger with Essilor in 2018.

EssilorLuxottica's network of scientists, researchers, engineers and designers work to gain a deeper understanding of the human visual system and the brain.

It is using its MedTech division to transform eye care into a more connected, efficient and patient-centric ecosystem, with early screening, prevention, advanced diagnostics and monitoring.

2. Geoff Martha

Company: Medtronic
Revenue: US$33.54bn
CEO since: 2020

Geoff Martha is Chairman and CEO of Medtronic, which aims to use technology to improve human welfare by alleviating pain, restoring health and extending life. 

Under his leadership, the company's medical innovations reach more than 78 million patients annually, targeting more than 70 conditions in the human body.

Before joining Medtronic, Geogg worked at GE Healthcare and GE Capital for almost two decades, working in business development, strategic marketing and sales management.

Geoff said on LinkedIn: "Meaningful connection starts with one question: how do we better serve others?

"Every decision we make at Medtronic is to ensure our Mission doesn't just show up as a slogan on a wall or a link on a website, but a responsibility we invest in every day – our superpower."

1. Joaquin Duato

Company: Johnson & Johnson MedTech
Revenue: US$33.8bn
CEO since: 2022

Joaquin Duato is the Chairman and CEO of Johnson & Johnson, which is one of the world's largest and most diversified healthcare products companies.

He joined J&J in 2005, working in the company's Ortho Biotech Products division, before taking on his first global leadership role in 2011.

J&J's MedTech division impacts the lives of more than 275 million patients each year, with innovative surgical technologies, orthopaedics, interventional solutions and vision technologies.

It is working to reimagine health by expanding patient access, improve outcomes, reduce health systems costs and drive value.

Joaquin said on LinkedIn: "Today, we are more focused than ever as we deliver breakthroughs that are transforming health for humanity."